{
  "trial_id": "NCT01435603",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, body mass index (BMI), fasting plasma glucose, 2-hour post-challenge plasma glucose, A1c, presence of Type 2 diabetes mellitus, blood pressure (systolic and diastolic), history of cardiovascular disease, history of lung disease, pregnancy status, use of medications known to produce hyperglycemia, presence of other diseases affecting glucose metabolism, ability to provide informed consent, language proficiency (English or Spanish).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Categorical",
          "presence of Type 2 diabetes mellitus"
        ],
        [
          "Categorical",
          "history of cardiovascular disease"
        ],
        [
          "Categorical",
          "history of lung disease"
        ],
        [
          "Categorical",
          "pregnancy status"
        ],
        [
          "Categorical",
          "use of medications known to produce hyperglycemia"
        ],
        [
          "Categorical",
          "presence of other diseases affecting glucose metabolism"
        ],
        [
          "Categorical",
          "ability to provide informed consent"
        ],
        [
          "Categorical",
          "language proficiency (English or Spanish)"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index (BMI)",
        "fasting plasma glucose",
        "2-hour post-challenge plasma glucose",
        "A1c",
        "blood pressure (systolic and diastolic)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, 2-hour Post-challenge Plasma Glucose, HbA1c, Physical Activity Level, Dietary Intake,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose",
        "2-hour Post-challenge Plasma Glucose",
        "HbA1c",
        "Physical Activity Level",
        "Dietary Intake"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, A1c, Dysglycemia Status, Diabetes Status, History of Cardiovascular Disease, History of Lung Disease, Pregnancy Status, Use of Glucose-Altering Medications, History of Abnormal Glucose Metabolism, Ability to Communicate with Research Staff, Ability to Read Written English or Spanish.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Fasting Plasma Glucose",
        "A1c",
        "Dysglycemia Status",
        "Diabetes Status",
        "History of Cardiovascular Disease",
        "History of Lung Disease",
        "Pregnancy Status",
        "Use of Glucose-Altering Medications",
        "History of Abnormal Glucose Metabolism",
        "Ability to Communicate with Research Staff",
        "Ability to Read Written English or Spanish."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index, fasting plasma glucose, 2-hour post-challenge plasma glucose, A1c, systolic blood pressure, diastolic blood pressure, medical history (cardiovascular disease, lung disease, etc.), medication use, smoking status, physical activity level, dietary habits.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Ethnicity (NIH/OMB)",
          "ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "body mass index",
        "fasting plasma glucose",
        "2-hour post-challenge plasma glucose",
        "A1c",
        "systolic blood pressure",
        "diastolic blood pressure",
        "medical history (cardiovascular disease, lung disease, etc.)",
        "medication use",
        "smoking status",
        "physical activity level",
        "dietary habits."
      ]
    }
  }
}